Advertisement
IBB vs IBBQ
Which Stock Would AI Choose? iShares Biotechnology ETF (IBB) vs. Invesco Nasdaq Biotechnology ETF (IBBQ) Stock Comparison
Key Takeaways
- IBB is the larger, more liquid fund with roughly $11 billion in assets, while IBBQ is a smaller, lower-cost vehicle with under $100 million in assets.
- IBB carries a 0.44% expense ratio, whereas IBBQ charges a notably lower 0.19%.
- Both funds delivered strong relative performance in recent months, with IBB posting a larger year-to-date gain and a heavier large-cap tilt than IBBQ.
- Tickeron AI Verdict: IBB currently holds the edge, reflecting greater liquidity, stronger recent momentum, and more consistent large-cap stability.
- For deeper detail, explore IBB Major News and IBB Today's Price Move, as well as IBBQ Major News and IBBQ Today's Price Move.
- To see which strategies are currently favored across the market, explore Trending AI Robots.
Introduction
Investors seeking targeted exposure to the biotechnology sector often compare exchange-traded funds (ETFs) that track similar indexes but differ meaningfully in cost, scale, and construction. The iShares Biotechnology ETF (IBB) and the Invesco Nasdaq Biotechnology ETF (IBBQ) are two such vehicles. Both provide access to companies engaged in drug discovery, development, and commercialization, yet they diverge in expense ratios, assets under management (AUM), and underlying benchmarks. This comparison is relevant for long-term investors, active traders, and anyone evaluating market positioning within healthcare innovation. Understanding these differences can clarify which fund aligns better with a given strategy, risk tolerance, and cost preference.
IBB Overview and Recent Performance
The iShares Biotechnology ETF (IBB) is among the largest and most widely traded biotechnology funds, with assets in excess of $11 billion and an expense ratio of 0.44%. The fund tracks an index of U.S.-listed biotechnology equities and is tilted toward large-cap names, with its top holdings concentrated in companies such as Gilead Sciences, Amgen, Vertex Pharmaceuticals, and Regeneron. This weighting gives IBB a comparatively stable, blue-chip character relative to more equal-weighted peers.
In recent market activity, IBB has been a standout within the healthcare complex, supported by robust merger and acquisition (M&A) activity as large pharmaceutical firms replenish pipelines ahead of patent expirations, along with positive trial results and favorable regulatory developments. The fund's year-to-date return has been among the strongest in its category, and its heavy large-cap orientation has helped it capture upside while smoothing some of the volatility associated with smaller biotech names.
IBBQ Overview and Recent Performance
The Invesco Nasdaq Biotechnology ETF (IBBQ) offers a lower-cost route into the sector, charging 0.19% while tracking the Nasdaq Biotechnology Index, a modified market-capitalization-weighted benchmark that includes both biotechnology and pharmaceutical companies listed on the Nasdaq Stock Market. Launched in 2021, the fund holds a broader basket of roughly 250 securities spanning large-, mid-, and small-cap firms, though its top positions still lean heavily on megacap biotech names.
In recent weeks, IBBQ has also benefited from the sector's positive momentum, posting a strong year-to-date advance and solid trailing twelve-month performance. However, its smaller AUM and thinner average trading volume mean lower liquidity and wider bid-ask spreads relative to IBB. These characteristics make IBBQ an efficient, cost-conscious option for buy-and-hold investors, while presenting practical considerations for frequent traders.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots chosen for their suitability to current market conditions. While Tickeron maintains a broad library of AI trading bots that monitor thousands of tickers, only the strongest performers and best-fit strategies earn placement in this featured section. These bots vary widely in trading style, timeframe, strategy, risk profile, and the specific tickers they trade, allowing users to evaluate performance statistics across many different approaches. The curated nature of the page helps traders focus on strategies demonstrating relevance in today's environment rather than sifting through the entire catalog. To explore which automated strategies are currently gaining traction, visit the Trending AI Robots page.
Head-to-Head Comparison
Although both funds track biotechnology-focused indexes, their construction creates distinct trade-offs. IBB skews toward established large-cap biotech companies, providing a more concentrated and stable profile with substantial liquidity and daily volume. IBBQ, by contrast, casts a wider net across the Nasdaq biotech and pharmaceutical universe, including mid- and small-cap names, while charging less than half the expense ratio of its larger rival.
On cost and diversification, IBBQ is the more economical and broadly diversified option. On scale, liquidity, and momentum, IBB holds the advantage. Risk factors are similar in theme—both are sensitive to clinical trial outcomes, regulatory decisions, and M&A cycles—but IBBQ's smaller-cap exposure can introduce additional single-stock and liquidity risk. Market sentiment has favored large-cap biotech in recent months, which has supported IBB's relative performance.
Tickeron AI Verdict
Based on observable factors such as trend consistency, relative positioning, and market liquidity, Tickeron's AI would likely favor IBB in the current environment. Its larger asset base, deeper trading volume, and large-cap bias have contributed to stronger recent momentum and greater stability amid a sector-wide rally. While IBBQ remains an attractive low-cost alternative for cost-sensitive investors, the combination of liquidity and relative strength tilts the probabilistic assessment toward IBB. This reflects a data-driven evaluation rather than a definitive forecast, and conditions may shift as market dynamics evolve.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBB is a Buy and IBBQ is a StrongBuy.
Aroon Indicator for IBB shows an upward move is likely
IBB's Aroon Indicator triggered a bullish signal on November 06, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 244 similar instances where the Aroon Indicator showed a similar pattern. In 214 of the 244 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on IBB as a result. In 79 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 87%.
The Moving Average Convergence Divergence (MACD) for IBB just turned positive on October 20, 2026. Looking at past instances where IBB's MACD turned positive, the stock continued to rise in 41 of 49 cases over the following month. The odds of a continued upward trend are 84%.
IBB moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IBB crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +3.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBB advanced for three days, in 276 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 50 of 62 cases where IBB's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
IBB broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Aroon Indicator for IBBQ shows an upward move is likely
IBBQ's Aroon Indicator triggered a bullish signal on November 06, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 257 similar instances where the Aroon Indicator showed a similar pattern. In 232 of the 257 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 26, 2026. You may want to consider a long position or call options on IBBQ as a result. In 74 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for IBBQ just turned positive on October 20, 2026. Looking at past instances where IBBQ's MACD turned positive, the stock continued to rise in 41 of 50 cases over the following month. The odds of a continued upward trend are 82%.
IBBQ moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IBBQ crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 75%.
Following a +3.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBBQ advanced for three days, in 263 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 58 of 70 cases where IBBQ's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBBQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
IBBQ broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
| IBB | IBBQ | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 3 days ago 81% | 3 days ago 83% |
| Momentum ODDS (%) | 3 days ago 87% | 3 days ago 83% |
| MACD ODDS (%) | 3 days ago 84% | 3 days ago 82% |
| TrendWeek ODDS (%) | 3 days ago 85% | 3 days ago 82% |
| TrendMonth ODDS (%) | 3 days ago 87% | 3 days ago 84% |
| Advances ODDS (%) | 5 days ago 85% | 5 days ago 82% |
| Declines ODDS (%) | 7 days ago 83% | 7 days ago 80% |
| BollingerBands ODDS (%) | 3 days ago 73% | 3 days ago 89% |
| Aroon ODDS (%) | 3 days ago 88% | 3 days ago 90% |
Advertisement
IBBQ and
Correlation & Price change
A.I.dvisor indicates that over the last year, IBBQ has been closely correlated with VRTX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if IBBQ jumps, then VRTX could also see price increases.
| Ticker / NAME | Correlation To IBBQ | 1D Price Change % | ||
|---|---|---|---|---|
| IBBQ | 100% | +2.08% | ||
| VRTX - IBBQ | 66% Closely correlated | +0.85% | ||
| CRSP - IBBQ | 64% Loosely correlated | +3.11% | ||
| EDIT - IBBQ | 63% Loosely correlated | +0.78% | ||
| AMGN - IBBQ | 61% Loosely correlated | +0.03% | ||
| BEAM - IBBQ | 60% Loosely correlated | +2.09% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DIEM | 38.56 | 0.76 | +2.00% |
| Franklin Emerging Market Core Dividend Tilt Index ETF (DIEM) | |||
| BROL | 25.29 | 0.28 | +1.12% |
| Baron Risk Optimized Large Cap ETF (BROL) | |||
| BAVA | 22.79 | N/A | N/A |
| Bitwise Avalanche ETF (BAVA) | |||
| CORP | 93.49 | -0.08 | -0.09% |
| PIMCO Investment Grade Corporate Bond Index ETF (CORP) | |||
| WDAI | 27.75 | -0.62 | -2.18% |
| Pacer S&P World 3AI Top 300 ETF (WDAI) | |||